Clinical Trials Directory

Trials / Completed

CompletedNCT05289440

Esketamine Administration on Recovery Quality After Radical Mastectomy

The Effect of Esketamine on the Quality of Recovery After Modified Radical Mastectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Anqing Municipal Hospital · Academic / Other
Sex
Female
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Some studies have reported that intravenous esketamine reduce postoperative pain intensity. The investigators investigated whether esketamine could improve the the quality of recovery after modified radical mastectomy.

Detailed description

A total of 111 patients were randomly allocated into 3 groups. Patients in group LE received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin. Patients in group HE received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin. Patients in group CON received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin.

Conditions

Interventions

TypeNameDescription
DRUGLow-dose esketamine infusionPatients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 2 µg/kg/min until before suture the skin.
DRUGHigh-dose esketamine infusionPatients received a bolus infusion of esketamine (0.5 mg/kg) before cutting the skin, and then esketamine was infused at a rate of 4 µg/kg/min until before suture the skin.
DRUGSaline infusionPatients received a bolus infusion of the same volume saline before cutting the skin, and then the same volume saline was infused until before suture the skin.

Timeline

Start date
2022-03-15
Primary completion
2022-09-15
Completion
2022-09-20
First posted
2022-03-21
Last updated
2022-11-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05289440. Inclusion in this directory is not an endorsement.